Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Pathway to Cures

Status
Global HQ
New York, United States
Countries of investment
    Investment stages
      Industries
        About
        Pathway to Cures operates a venture philanthropy fund dedicated to investing in innovative therapies and technologies aimed at transforming the lives of individuals affected by inheritable blood and bleeding disorders.
        Min check size
        -
        Max check size
        -
        Fund size
        NPS

        Investment Thesis

        Lead investor
        Co Invest
        Number of exits
        Preferred contact method

        Manager's Experience

        With a robust background in healthcare and technology investments, the fund manager has successfully led over 25 deals across North America and Europe. Their operator-first approach emphasizes strategic partnerships, enabling them to identify and nurture high-potential startups at the growth stage. Notable exits include several transformative companies that have significantly advanced innovation in their respective fields. Committed to a data-driven investment strategy, they consistently seek out thematic opportunities that align with market trends and emerging needs.

        Pathway to Cures Contacts Information

        Primary contact

        Fund number
        Vintage Year
        Net Internal Rate of Return
        Investment Multiple
        Capital Allocation
        Management Fee
        Carried Interest
        AUM
        Follow-on Investments
        Graduation Rate
        Write-Off Ratio
        Last profile update timestamp